The effect of Centella asiatica L. on cognitive disorders in MS
Phase 3
- Conditions
- Multiple sclerosis (MS).Demyelinating diseases of the central nervous systemG35-G37
- Registration Number
- IRCT20161108030776N5
- Lead Sponsor
- Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 96
Inclusion Criteria
Multiple sclerosis patients with complaints of cognitive impairment referred to the MS clinic and had proven cognitive impairment based on the BICAMS (brief international cognitive assessment for MS) test.
Exclusion Criteria
Suffering from psychiatric diseases such as severe depression, schizophrenia, etc.
pregnancy
breastfeeding
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of cognitive impairment. Timepoint: Investigation of cognitive impairment at the beginning of the study (before the start of the intervention) and two months after the start of the intervention with the Centella asiatica. Method of measurement: BICAMS questionnaire.;Quality of Life. Timepoint: At the beginning of the study (before the start of the intervention) and two months after the start of Centella Asiatica. Method of measurement: MSQOL54 questionnaire.
- Secondary Outcome Measures
Name Time Method Possible side effects. Timepoint: At the end of the study. Method of measurement: Registration by the patient and questions from the patient.